Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy of anti-HER3 antibodies

Combination therapy of anti-HER3 antibodies

US Patent 9180185 · Granted Nov 10, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins specific for CD137 and GPC32025
Dosing for combination treatment with anti-CD20/anti-CD3 bispecific antibody and2025
Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-2022
HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain I2020
Nucleic acid encoding dual Fc antigen binding proteins2020
HER3 antigen binding proteins binding to the beta-hairpin of HER32020
Monovalent antigen binding proteins2020
Combination IL-2 immunoconjugate therapy2020
Anti-TPBG antibodies and methods of use2019
Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairp2019
Antibodies against human CSF-1R and uses thereof2019
Antibodies against human CSF-1R and uses thereof2019